Literature DB >> 10827432

The economic burden of lymphatic filariasis in India.

K D Ramaiah1, P K Das, E Michael, H Guyatt.   

Abstract

Lymphatic filariasis affects 119 million people living in 73 countries, with India accounting for 40% of the global prevalence of infection. Despite its debilitating effects, lymphatic filariasis is given very low control priority. One of the reasons for this is paucity of information on the economic burden of the disease. Recent studies in rural areas of south India have shown that the treatment costs and loss of work time due to the disease are considerable. Based on the results of these studies, Kapa Ramaiah et al. here estimate the annual economic loss because of lymphatic filariasis for India and discuss the implications of their findings.

Entities:  

Mesh:

Year:  2000        PMID: 10827432     DOI: 10.1016/s0169-4758(00)01643-4

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  75 in total

1.  Low density microfilaraemia as a causative agent in a case of unexplained ascitis of suspicious nature.

Authors:  Rahul Mannan; Tejinder Singh Bhasin; Mridu Manjari; Vatsala Misra
Journal:  J Clin Diagn Res       Date:  2013-07-01

Review 2.  Diurnally subperiodic filariasis in India-prospects of elimination: precept to action?

Authors:  A N Shriram; K Krishnamoorthy; B P Saha; Avijit Roy; V Kumaraswami; W A Shah; P Jambulingam; P Vijayachari
Journal:  Parasitol Res       Date:  2011-02-01       Impact factor: 2.289

Review 3.  Are coinfections of malaria and filariasis of any epidemiological significance?

Authors:  Ephantus J Muturi; Benjamin G Jacob; Chang-Hyun Kim; Charles M Mbogo; Robert J Novak
Journal:  Parasitol Res       Date:  2007-11-20       Impact factor: 2.289

4.  Probability risk transmission matrix as a decision tool for assessing methods of transmission interruption of Wuchereria bancrofti infection.

Authors:  P K DAS; P Vanamail
Journal:  Epidemiol Infect       Date:  2007-06-20       Impact factor: 2.451

5.  Investing in justice: ethics, evidence, and the eradication investment cases for lymphatic filariasis and onchocerciasis.

Authors:  Theodore C Bailey; Maria W Merritt; Fabrizio Tediosi
Journal:  Am J Public Health       Date:  2015-02-25       Impact factor: 9.308

6.  Eco-friendly microbial route to synthesize cobalt nanoparticles using Bacillus thuringiensis against malaria and dengue vectors.

Authors:  Sampath Marimuthu; Abdul Abdul Rahuman; Arivarasan Vishnu Kirthi; Thirunavukkarasu Santhoshkumar; Chidambaram Jayaseelan; Govindasamy Rajakumar
Journal:  Parasitol Res       Date:  2013-09-08       Impact factor: 2.289

7.  Immunization with Wuchereria bancrofti Glutathione-S-transferase Elicits a Mixed Th1/Th2 Type of Protective Immune Response Against Filarial Infection in Mastomys.

Authors:  Dhananjay Andure; Kiran Pote; Vishal Khatri; Nitin Amdare; Ramchandra Padalkar; Maryada Venkata Rami Reddy
Journal:  Indian J Clin Biochem       Date:  2016-02-09

8.  Chemical composition, larvicidal and antioxidant activities of latex from Garcinia morella (Gaertn.) Desr.

Authors:  Hosakatte Niranjana Murthy; Kadanthottu Sebastian Joseph; Shivanand Payamalle; Dayanand Dalawai; Vinayak Ganapumane
Journal:  J Parasit Dis       Date:  2016-11-15

9.  The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).

Authors:  Brian K Chu; Pamela J Hooper; Mark H Bradley; Deborah A McFarland; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

10.  Larvicidal activity of some Euphorbiaceae plant extracts against Aedes aegypti and Culex quinquefasciatus (Diptera: Culicidae).

Authors:  A Abdul Rahuman; Geetha Gopalakrishnan; P Venkatesan; Kannappan Geetha
Journal:  Parasitol Res       Date:  2007-12-29       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.